Join to View Full Profile
3855 Health Sciences DrLa Jolla, CA 92093
Phone+1 858-657-7000
Fax+1 858-822-6844
Dr. Koura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2006 - 2009
- Washington University in St. Louis School of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2013 - 2026
- GA State Medical License 2011 - 2014
- HI State Medical License 2009 - 2012
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation Start of enrollment: 2019 Nov 26
Publications & Presentations
PubMed
- A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.Divya Koura, Kaitlyn Dykes, Aaron Goodman, Caitlin Costello, Carolyn Mulroney
Blood Advances. 2025-08-26 - Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement.Ibrahim N Muhsen, Gregory W Roloff, Rawan Faramand, Tamer Othman, Yannis Valtis
Blood Advances. 2025-08-26 - The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.Timothy E O'Connor, Chenyu Lin, Gregory W Roloff, Amy Zhang, Katharine Miller
Bone Marrow Transplantation. 2025-08-23
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: